Moderate riskFDA DrugClass II

Mylan prasugrel 10 mg tablets recalled for failed dissolution testing

Mylan Pharmaceuticals is recalling Prasugrel 10mg tablets (Lot #3225272, expiring September 30, 2026) because they failed dissolution testing during 18-month stability studies. This means the tablets may not break down and release the medication as intended in the body. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Mylan recalls

What to do

  1. Check if you have Prasugrel 10mg tablets with lot #3225272 and expiration date September 30, 2026.
  2. Contact your pharmacist or doctor before stopping the medication—do not stop taking it without medical guidance.
  3. Return affected bottles to your pharmacy or follow your doctor's instructions for safe disposal.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
47,662 bottles
Illnesses reported
None reported
Manufactured in
3711 Collins Ferry Rd, N/A, Morgantown, WV, United States
Classification
Class II
Recall number
D-0839-2026

In the FDA's words

Description
Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93. Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria Lot #: 3225272, Exp. September 30, 2026 Distribution: Nationwide within the U.S Affected quantity: 47,662 bottles
Hazard
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

More from Mylan

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug